Skip to main content
logo
LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
3.190
-0.110 (-3.33%)
At close: Oct 20, 2026, 4:00 PM EDT
3.250
+0.060 (1.88%)
Pre-market: Oct 21, 2026, 7:33 AM EDT

LENZ Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
100501794---
Market Cap Growth
-90.22%-36.94%----
Enterprise Value
-119299578---
Last Close Price
3.1916.0028.87---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
4.6726.23----
PB Ratio
0.461.763.89---
P/TBV Ratio
0.461.763.89---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-15.69----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.010.010.01-
Net Debt / Equity Ratio
-1.00-1.02-1.02-1.27-1.19-1.07
Net Debt / EBITDA Ratio
1.623.213.550.904.222.74
Net Debt / FCF Ratio
1.924.173.471.0810.713.39
Asset Turnover
0.100.07--0.46-
Quick Ratio
12.9113.9120.193.554.6814.61
Current Ratio
13.5514.2320.363.634.9114.62
Return on Equity (ROE)
-59.21%-33.63%-38.94%-157.61%-39.80%-
Return on Assets (ROA)
-37.36%-21.86%-25.64%-77.17%-20.07%-
Return on Capital Employed (ROCE)
-61.80%-32.00%-28.60%-139.70%-28.00%-39.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-125.71%-16.40%-6.27%---
FCF Yield
-114.16%-13.98%-7.54%---
Buyback Yield / Dilution
-10.84%-35.39%-986.27%79.28%-1.05%-
SEC Filings: 10-K · 10-Q